Zeolite-based anti-diarrheic medication
Four clinical studies were conducted using a zeolite-based anti-diarrheic medication. In the first study, 18 men and 15 women were each treated with 3 to 6 tablets of zeolite (900mg.)every 3 hours. In the second study, 72 volunteer patients with acute diarrhea were treated with the same dosage in the first study. The third study was a comparative study in which diabetic patients with vascular impairments (neuropathic diarrhea) were either given a zeolite-based anti-medication or an antimotility drug. Due to vascular impairments, recovery of patients must be achieved within 24 hours. The results revealed no significant difference. Further, the study demonstrated that a second dose of the zeolite-based anti-diarrheic medication had no adverse side effects, a benefit that the antimotility drug could not boast. In a fourth study, 435 volunteers with acute diarrhea resulting from food poisoning (the main cause of acute diarrhea in adults) were treated with the zeolite-based anti-diarrheic. 75% of the patients recovered from the diarrhea within 24 hours and the remaining 25% recovered during the following 12 hours.
Almost all the patients showed good tolerance to treatment with the zeolite-based anti-diarrheic and none dropped out of the four clinical trails due to side effects.
Rodriguez-Fuentes G, Barrios MA 1997,
Zeolites 19:441-448